Cargando…
Apatinib inhibits tumor growth and angiogenesis in PNET models
Angiogenesis has a pivotal role in the growth and metastasis of pancreatic neuroendocrine tumors (PNETs). Apatinib inhibits angiogenesis as a highly selective KDR inhibitor and has been used to treat advanced gastric cancer and malignancies in clinical settings. However, the efficacy of apatinib in...
Autores principales: | Wu, Shan, Zhou, Jianjun, Guo, Jing, Hua, Zhan, Li, Jianchen, Wang, Zai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bioscientifica Ltd
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6330719/ https://www.ncbi.nlm.nih.gov/pubmed/30557852 http://dx.doi.org/10.1530/EC-18-0397 |
Ejemplares similares
-
Apatinib inhibits VEGFR-2 and angiogenesis in an in vivo murine model of nasopharyngeal carcinoma
por: Peng, Qiu-Xia, et al.
Publicado: (2017) -
Vascular NRP2 triggers PNET angiogenesis by activating the SSH1-cofilin axis
por: Luo, Xi, et al.
Publicado: (2020) -
Primitive neuroectodermal tumor (PNET) of the lung in an adult woman
por: Gachechiladze, Mariam, et al.
Publicado: (2014) -
Characteristics of human Ewing/PNET sarcoma models
por: Teicher, Beverly A., et al.
Publicado: (2011) -
Congenital sacrococcygeal PNET and chemotherapy
por: Hawkes, Colin Patrick, et al.
Publicado: (2012)